Lobe Sciences Ltd. (CSE:LOBE)
Canada · Delayed Price · Currency is CAD 0.0850
+0.0050 (6.25%)
Aug 28, 2026, 9:04 AM EST
Lobe Sciences Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
28.30M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | - | - | - |
| Aug 31, 2024 | 136.21K | -704.33K | -83.80% |
| Aug 31, 2023 | 840.53K | - | - |
| Aug 31, 2022 | - | - | - |
| Aug 31, 2021 | - | - | - |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Telescope Innovations | 7.30M |
| Devonian Health Group | 3.00M |
| Pharmala Biotech Holdings | 1.27M |
| Onco-Innovations | 110.38K |
| The More Life Company | 65.00K |
Lobe Sciences News
- 2 days ago - Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement - Accesswire
- 2 days ago - Lobe Sciences Expands Leadership Team with New CFO Appointment - Accesswire
- 10 days ago - Lobe Sciences Ltd. Announces Closing of Non-Brokered Private Placement - Accesswire
- 12 days ago - Lobe Sciences Reports Third Quarter 2026 Financial Results - Accesswire
- 18 days ago - Lobe Sciences Ltd. Announces Non-Brokered Private Placement - Accesswire
- 25 days ago - Lobe Sciences Announces Results of Annual General and Special Meeting of Shareholders - Accesswire
- 7 weeks ago - Lobe Sciences Files Management Information Circular for Annual General and Special Meeting on July 30, 2026 - Accesswire
- 2 months ago - Lobe Sciences Directors and Management Increase Equity Ownership Through Settlement of Accrued Fees by the Issuance of Common Shares - Accesswire